mibefradil has been researched along with Cancer of the Thyroid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flockerzi, V; Hofmann, F; Mehrke, G; Zong, XG | 1 |
1 other study(ies) available for mibefradil and Cancer of the Thyroid
| Article | Year |
|---|---|
The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Calcium Channels; CHO Cells; Cricetinae; Humans; Mibefradil; Tetrahydronaphthalenes; Thyroid Neoplasms; Tumor Cells, Cultured | 1994 |